Category | CBD-related violations | Total violations |
---|---|---|
n (%) | n (%) | |
Month of issuance | ||
March, 2020 | 1 (6.7) | 12 (9.2) |
April, 2020 | 4 (26.7) | 28 (21.5) |
May, 2020 | 4 (26.7) | 26 (20.0) |
June, 2020 | 1 (6.7) | 8 (6.2) |
July, 2020 | 0 (0.0) | 11 (8.5) |
August, 2020 | 1 (6.7) | 6 (4.6) |
September, 2020 | 0 (0.0) | 2 (1.5) |
October, 2020 | 1 (6.7) | 4 (3.0) |
November, 2020 | 0 (0.0) | 2 (1.5) |
December, 2020 | 1 (6.7) | 7 (5.4) |
January, 2021 | 0 (0.0) | 4 (3.1) |
February, 2021 | 0 (0.0) | 1 (0.8) |
March, 2021 | 1 (6.7) | 3 (2.3) |
April, 2021 | 0 (0.0) | 4 (3.1) |
May, 2021 | 0 (0.0) | 4 (3.1) |
June, 2021 | 0 (0.0) | 1 (0.8) |
July, 2021 | 1 (6.7) | 4 (3.1) |
August, 2021 | 0 (0.0) | 3 (2.3) |
Promotional venue | ||
Website | 15 (100.0) | 128 (98.5) |
8 (53.3) | 49 (37.7) | |
YouTube | 0 (0.0) | 6 (4.6) |
4 (26.7) | 15 (11.5) | |
5 (33.3) | 20 (15.4) | |
1 (6.7) | 3 (2.3) | |
0 (0.0) | 1 (0.8) | |
Type of violation | ||
Unapproved product | 15 (100.0) | 130 (100.0) |
Misbranding | 15 (100.0) | 127 (97.7) |
Unsubstantiated claims | 14 (93.3) | 115 (88.5) |
Mechanism of action | ||
Anti-viral | 5 (33.3) | - |
Pro-inflammatory | 1 (6.7) | - |
Anti-inflammatory | 7 (46.7) | - |
Immune-booster | 6 (40.0) | - |
Immune-suppressor | 2 (13.3) | - |
Other | 2 (13.3) | - |